Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bernhardt

Showing results (41-50 of 193) with videos related to

Pageof 20
Sort By:
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Hyaluronidase significantly enhances the efficacy of regional vinblastine chemotherapy of malignant melanomaT Spruss, G Bernhardt, H Schönenberger, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Different response of murine and human mammary tumour models to a series of diastereoisomeric [1,2-bis(difluorophenyl) ethylenediamine]dichloroplatinum(II) complexesT Spruss, G Bernhardt, E Schickaneder, et al.
Molecular Microbiology|September 1, 2020
Cell division is antagonized by the activity of peptidoglycan endopeptidases that promote cell elongationThao T Truong, Andrea Vettiger, Thomas G Bernhardt
Planta Medica|September 14, 1999
Antispasmodic activity of Thymus vulgaris extract on the isolated guinea-pig trachea: discrimination between drug and ethanol effectsA Meister, G Bernhardt, V Christoffel, et al.
Archiv Der Pharmazie|January 5, 2002
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compoundR Schlemmer, T Spruss, G Bernhardt, et al.
Cancer Letters|December 5, 1998
Pharmacokinetics and tissue distribution of bovine testicular hyaluronidase and vinblastine in mice: an attempt to optimize the mode of adjuvant hyaluronidase administration in cancer chemotherapyI Muckenschnabel, G Bernhardt, T Spruss, et al.
The Journal of Biological Chemistry|January 9, 1999
Identification and characterization of the cis-acting elements of the human CD155 gene core promoterD Solecki, E Wimmer, M Lipp, et al.
The Journal of Biological Chemistry|April 25, 2000
Identification of a nuclear respiratory factor-1 binding site within the core promoter of the human polio virus receptor/CD155 geneD Solecki, G Bernhardt, M Lipp, et al.
Archiv Der Pharmazie|February 24, 2001
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part II. Studies on the influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) on the specific immune defense in MXT-M-3,2 breast cancer bearing miceR Schlemmer, T Spruss, G Bernhardt, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Antitumour activity of miltefosine alone and after combination with platinum complexes on MXT mouse mammary carcinoma modelsT Spruss, G Bernhardt, H Schönenberger, et al.
Pageof 20

Showing results (41-50 of 193) with videos related to

Sort By:
Pageof 20
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Hyaluronidase significantly enhances the efficacy of regional vinblastine chemotherapy of malignant melanomaT Spruss, G Bernhardt, H Schönenberger, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Different response of murine and human mammary tumour models to a series of diastereoisomeric [1,2-bis(difluorophenyl) ethylenediamine]dichloroplatinum(II) complexesT Spruss, G Bernhardt, E Schickaneder, et al.
Molecular Microbiology|September 1, 2020
Cell division is antagonized by the activity of peptidoglycan endopeptidases that promote cell elongationThao T Truong, Andrea Vettiger, Thomas G Bernhardt
Planta Medica|September 14, 1999
Antispasmodic activity of Thymus vulgaris extract on the isolated guinea-pig trachea: discrimination between drug and ethanol effectsA Meister, G Bernhardt, V Christoffel, et al.
Archiv Der Pharmazie|January 5, 2002
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compoundR Schlemmer, T Spruss, G Bernhardt, et al.
Cancer Letters|December 5, 1998
Pharmacokinetics and tissue distribution of bovine testicular hyaluronidase and vinblastine in mice: an attempt to optimize the mode of adjuvant hyaluronidase administration in cancer chemotherapyI Muckenschnabel, G Bernhardt, T Spruss, et al.
The Journal of Biological Chemistry|January 9, 1999
Identification and characterization of the cis-acting elements of the human CD155 gene core promoterD Solecki, E Wimmer, M Lipp, et al.
The Journal of Biological Chemistry|April 25, 2000
Identification of a nuclear respiratory factor-1 binding site within the core promoter of the human polio virus receptor/CD155 geneD Solecki, G Bernhardt, M Lipp, et al.
Archiv Der Pharmazie|February 24, 2001
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part II. Studies on the influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) on the specific immune defense in MXT-M-3,2 breast cancer bearing miceR Schlemmer, T Spruss, G Bernhardt, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Antitumour activity of miltefosine alone and after combination with platinum complexes on MXT mouse mammary carcinoma modelsT Spruss, G Bernhardt, H Schönenberger, et al.
Pageof 20